$8.85
0.18[2.08%]
At close: Apr 19
$8.85
0[0.00%]
After Hours: 4:00PM EDT
Zymeworks
(NASDAQ:ZYME)Latest News for Zymeworks Stock (NASDAQ:ZYME)
Zymeworks Stock (NASDAQ: ZYME)
Categories: All
Monday, April 08, 2024
Tuesday, March 12, 2024
Monday, March 11, 2024
Wednesday, March 06, 2024
Tuesday, March 05, 2024
Monday, January 22, 2024
Monday, January 15, 2024
Thursday, January 04, 2024
Tuesday, December 26, 2023
- Zymeworks shares are trading higher after the company entered into a securities purchase agreement with EcoR1 Capital for gross proceeds of $50 million.Benzinga Newsdesk - Dec 26, 2023, 3:34PM
- Zymeworks Entered Into A Securities Purchase Agreement With EcoR1 Capital For 5.1M Pre-funded Warrants To Purchase 5.1M Shares In A Private Placement For $9.8299/Pre-funded Warrant With Gross Proceeds Of $50MBenzinga Newsdesk - Dec 26, 2023, 8:03AM
Monday, December 04, 2023
Tuesday, November 07, 2023
Thursday, November 02, 2023
Monday, October 16, 2023
Monday, September 25, 2023
Thursday, September 21, 2023
- Zymeworks In Connection With Entry Into Termination, On Sept 18, 2023, Co's Unit, Beigene Entered Into 3rd Amendment To License & Collaboration Deal; Unit Eligible To Receive Tiered Royalties Ranging High Single Digit Percentages Up To 19.5% On Net SalesBenzinga Newsdesk - Sep 21, 2023, 4:42PM
- Zymeworks Inc Says Termination Doesn't Relieve Parties From Obligations Under Zanidatamab Zovodotin License & Collaboration Deal Accrued Prior To TerminationBenzinga Newsdesk - Sep 21, 2023, 4:41PM
- Zymeworks Inc Says Termination Agreement Does Not Terminate The Zanidatamab License And Collaboration AgreementBenzinga Newsdesk - Sep 21, 2023, 4:40PM
- On Sept 18, Zymeworks' Unit & Beigene Entered Into Termination Agreement For License And Collaboration Agreement Of Zanidatamab ZovodotinBenzinga Newsdesk - Sep 21, 2023, 4:30PM